Weiguang Xue

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 4

Top Topics

Tyrosine Kinase

Network Analysis

Small Cell Lung Cancer

Top Venues

Journal of medical economics

Future oncology (London, England)

Journal of cutaneous medicine and surgery

This page only lists publications with an associated author ORCID identifier.

Publications

Min Huang, Peter A Fasching, Amin Haiderali, Weiguang Xue, Wilbur Pan, Vassiliki Karantza, Fan Yang, James Truscott, Yiqiao Xin, Joyce O'Shaughnessy
Association between event-free survival and overall survival in early-stage triple-negative breast cancer. Future oncology (London, England) (2023)
Beilei Cai, Zheng-Yi Zhou, Weiguang Xue, Nisha C Hazra, Mukesh Singh, Dinesh Mishra, Diana Brixner, Gary Oderda, Joseph Biskupiak
Budget impact of capmatinib for adults with metastatic non-small cell lung cancer harboring a MET exon 14 skipping mutation in the United States. Journal of medical economics 24 (1) (2021)
Weiguang Xue, Rinat Ribalov, Zheng-Yi Zhou, Rajeev Ayyagari, Sam Leo
Re: Ganz ML, Chavan A, Dhanda R, et al. Cost-effectiveness of valbenazine compared with deutetrabenazine for the treatment of tardive dyskinesia. J Med Econ. 2021;24(1):103-113. Journal of medical economics 24 (1) (2021)
Weiguang Xue, Paranjoy Saharia, Emma Gray, Shoghag Khoudigian-Sinani, Véronique Gaudet, Martin Barbeau, Kim Papp
Efficacy of Brodalumab for Moderate to Severe Plaque Psoriasis: A Canadian Network Meta-Analysis. Journal of cutaneous medicine and surgery 24 (6) (2020)